Skip to main content
SpringerLink
Log in

Magnetic resonance imaging patterns of muscle involvement in genetic muscle diseases: a systematic review

  • Review
  • Published:
Journal of Neurology Aims and scope Submit manuscript

Abstract

A growing body of the literature supports the use of magnetic resonance imaging as a potential biomarker for disease severity in the hereditary myopathies. We performed a systematic review of the medical literature to evaluate patterns of fat infiltration observed in magnetic resonance imaging studies of muscular dystrophy and congenital myopathy. Searches were performed using MEDLINE, EMBASE, and grey literature databases. Studies that described fat infiltration of muscles in patients with muscular dystrophy or congenital myopathy were selected for full-length review. Data on preferentially involved or spared muscles were extracted for analysis. A total of 2172 titles and abstracts were screened, and 70 publications met our criteria for inclusion in the systematic review. There were 23 distinct genetic disorders represented in this analysis. In most studies, preferential involvement and sparing of specific muscles were reported. We conclude that magnetic resonance imaging studies can be used to identify distinct patterns of muscle involvement in the hereditary myopathies. However, larger studies and standardized methods of reporting are needed to develop imaging as a diagnostic tool in these diseases.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

References

  1. Murphy WA, Totty WG, Carroll JE (1986) MRI of normal and pathologic skeletal muscle. AJR Am J Roentgenol 146(3):565–574. doi:10.2214/ajr.146.3.565

    Article  CAS  PubMed  Google Scholar 

  2. Del Grande F, Carrino JA, Del Grande M, Mammen AL, Christopher Stine L (2011) Magnetic resonance imaging of inflammatory myopathies. Top Magn Reson Imaging TMRI 22(2):39–43. doi:10.1097/RMR.0b013e31825b2c35

    Article  PubMed  Google Scholar 

  3. Mercuri E, Pichiecchio A, Allsop J, Messina S, Pane M, Muntoni F (2007) Muscle MRI in inherited neuromuscular disorders: past, present, and future. J Magn Reson Imaging JMRI 25(2):433–440. doi:10.1002/jmri.20804

    Article  PubMed  Google Scholar 

  4. Wattjes MP, Kley RA, Fischer D (2010) Neuromuscular imaging in inherited muscle diseases. Eur Radiol 20(10):2447–2460. doi:10.1007/s00330-010-1799-2

    Article  PubMed  PubMed Central  Google Scholar 

  5. Tawil R, Padberg GW, Shaw DW, van der Maarel SM, Tapscott SJ, Participants FW (2016) Clinical trial preparedness in facioscapulohumeral muscular dystrophy: clinical, tissue, and imaging outcome measures 29–30 May 2015, Rochester, New York. Neuromuscul Disord NMD 26(2):181–186. doi:10.1016/j.nmd.2015.10.005

    Article  PubMed  Google Scholar 

  6. Higgins JPT, Green S (2008) Cochrane Collaboration. Cochrane handbook for systematic reviews of interventions., Cochrane book seriesWiley-Blackwell, Chichester

    Book  Google Scholar 

  7. Moher D, Liberati A, Tetzlaff J, Altman DG, Group P (2009) Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. J Clin Epidemiol 62(10):1006–1012. doi:10.1016/j.jclinepi.2009.06.005

    Article  PubMed  Google Scholar 

  8. Faridian-Aragh N, Wagner KR, Leung DG, Carrino JA (2014) Magnetic resonance imaging phenotyping of Becker muscular dystrophy. Muscle Nerve 50(6):962–967. doi:10.1002/mus.24246

    Article  PubMed  Google Scholar 

  9. Tasca G, Iannaccone E, Monforte M, Masciullo M, Bianco F, Laschena F, Ottaviani P, Pelliccioni M, Pane M, Mercuri E, Ricci E (2012) Muscle MRI in Becker muscular dystrophy. Neuromuscul Disord NMD 22(Suppl 2):S100–S106. doi:10.1016/j.nmd.2012.05.015

    Article  PubMed  Google Scholar 

  10. Loughran T, Higgins DM, McCallum M, Coombs A, Straub V, Hollingsworth KG (2015) Improving highly accelerated fat fraction measurements for clinical trials in muscular dystrophy: origin and quantitative effect of R2* changes. Radiology 275(2):570–578. doi:10.1148/radiol.14141191

    Article  PubMed  Google Scholar 

  11. van den Bergen JC, Wokke BH, Janson AA, van Duinen SG, Hulsker MA, Ginjaar HB, van Deutekom JC, Aartsma-Rus A, Kan HE, Verschuuren JJ (2014) Dystrophin levels and clinical severity in Becker muscular dystrophy patients. J Neurol Neurosurg Psychiatry 85(7):747–753. doi:10.1136/jnnp-2013-306350

    Article  PubMed  Google Scholar 

  12. Tasca G, Monforte M, Iannaccone E, Laschena F, Ottaviani P, Silvestri G, Masciullo M, Mirabella M, Servidei S, Ricci E (2012) Muscle MRI in female carriers of dystrophinopathy. Eur J Neurol 19(9):1256–1260. doi:10.1111/j.1468-1331.2012.03753.x

    Article  CAS  PubMed  Google Scholar 

  13. Kim HK, Laor T, Horn PS, Racadio JM, Wong B, Dardzinski BJ (2010) T2 mapping in Duchenne muscular dystrophy: distribution of disease activity and correlation with clinical assessments. Radiology 255(3):899–908. doi:10.1148/radiol.10091547

    Article  PubMed  Google Scholar 

  14. Gaeta M, Messina S, Mileto A, Vita GL, Ascenti G, Vinci S, Bottari A, Vita G, Settineri N, Bruschetta D, Racchiusa S, Minutoli F (2012) Muscle fat-fraction and mapping in Duchenne muscular dystrophy: evaluation of disease distribution and correlation with clinical assessments preliminary experience. Skelet Radiol 41(8):955–961

    Article  Google Scholar 

  15. Kim HK, Merrow AC, Shiraj S, Wong BL, Horn PS, Laor T (2013) Analysis of fatty infiltration and inflammation of the pelvic and thigh muscles in boys with Duchenne muscular dystrophy (DMD): grading of disease involvement on MR imaging and correlation with clinical assessments. Pediatr Radiol 43(10):1327–1335. doi:10.1007/s00247-013-2696-z

    Article  PubMed  Google Scholar 

  16. Liu GC, Jong YJ, Chiang CH, Jaw TS (1993) Duchenne muscular dystrophy: MR grading system with functional correlation. Radiology 186(2):475–480. doi:10.1148/radiology.186.2.8421754

    Article  CAS  PubMed  Google Scholar 

  17. Garrood P, Hollingsworth KG, Eagle M, Aribisala BS, Birchall D, Bushby K, Straub V (2009) MR imaging in Duchenne muscular dystrophy: quantification of T1-weighted signal, contrast uptake, and the effects of exercise. J Magn Reson Imaging JMRI 30(5):1130–1138. doi:10.1002/jmri.21941

    Article  PubMed  Google Scholar 

  18. Li W, Zheng Y, Zhang W, Wang Z, Xiao J, Yuan Y (2015) Progression and variation of fatty infiltration of the thigh muscles in Duchenne muscular dystrophy, a muscle magnetic resonance imaging study. Neuromuscul Disord NMD 25(5):375–380. doi:10.1016/j.nmd.2015.01.003

    Article  PubMed  Google Scholar 

  19. Ponrartana S, Ramos-Platt L, Wren TAL, Hu HH, Perkins TG, Chia JM, Gilsanz V (2014) Effectiveness of diffusion tensor imaging in assessing disease severity in Duchenne muscular dystrophy: preliminary study. Pediatr Radiol ((Ponrartana S., sponrartana@chla.usc.edu; Wren T.A.L.; Hu H.H.; Gilsanz V.) Department of Radiology, Children’s Hospital Los Angeles, Los Angeles, United States)

  20. Wokke BH, van den Bergen JC, Versluis MJ, Niks EH, Milles J, Webb AG, van Zwet EW, Aartsma-Rus A, Verschuuren JJ, Kan HE (2014) Quantitative MRI and strength measurements in the assessment of muscle quality in Duchenne muscular dystrophy. Neuromuscul Disord NMD 24(5):409–416. doi:10.1016/j.nmd.2014.01.015

    Article  CAS  PubMed  Google Scholar 

  21. Kinali M, Arechavala-Gomeza V, Cirak S, Glover A, Guglieri M, Feng L, Hollingsworth KG, Hunt D, Jungbluth H, Roper HP, Quinlivan RM, Gosalakkal JA, Jayawant S, Nadeau A, Hughes-Carre L, Manzur AY, Mercuri E, Morgan JE, Straub V, Bushby K, Sewry C, Rutherford M, Muntoni F (2011) Muscle histology vs MRI in Duchenne muscular dystrophy. Neurology 76(4):346–353. doi:10.1212/WNL.0b013e318208811f

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  22. Torriani M, Townsend E, Thomas BJ, Bredella MA, Ghomi RH, Tseng BS (2012) Lower leg muscle involvement in Duchenne muscular dystrophy: an MR imaging and spectroscopy study. Skelet Radiol 41(4):437–445. doi:10.1007/s00256-011-1240-1

    Article  Google Scholar 

  23. Vohra RS, Lott D, Mathur S, Senesac C, Deol J, Germain S, Bendixen R, Forbes SC, Sweeney HL, Walter GA, Vandenborne K (2015) Magnetic resonance assessment of hypertrophic and pseudo-hypertrophic changes in lower leg muscles of boys with Duchenne muscular dystrophy and their relationship to functional measurements. PLoS One 10(6):e0128915. doi:10.1371/journal.pone.0128915

    Article  PubMed  PubMed Central  Google Scholar 

  24. Ricotti V, Evans MR, Sinclair CD, Butler JW, Ridout DA, Hogrel JY, Emira A, Morrow JM, Reilly MM, Hanna MG, Janiczek RL, Matthews PM, Yousry TA, Muntoni F, Thornton JS (2016) Upper limb evaluation in Duchenne muscular dystrophy: fat-water quantification by mri, muscle force and function define endpoints for clinical trials. PLoS One 11(9):e0162542. doi:10.1371/journal.pone.0162542

    Article  PubMed  PubMed Central  Google Scholar 

  25. Polavarapu K, Manjunath M, Preethish-Kumar V, Sekar D, Vengalil S, Thomas P, Sathyaprabha TN, Bharath RD, Nalini A (2016) Muscle MRI in Duchenne muscular dystrophy: evidence of a distinctive pattern. Neuromuscul Disord NMD. doi:10.1016/j.nmd.2016.09.002

    PubMed  Google Scholar 

  26. Bing Q, Hu K, Tian Q, Zhao Z, Shen H, Li N, Hu J (2016) Semi-quantitative assessment of lower limb MRI in dystrophinopathy. Int J Clin Exp Med 9(7):13723–13732

    Google Scholar 

  27. Godi C, Ambrosi A, Nicastro F, Previtali SC, Santarosa C, Napolitano S, Iadanza A, Scarlato M, Natali Sora MG, Tettamanti A, Gerevini S, Cicalese MP, Sitzia C, Venturini M, Falini A, Gatti R, Ciceri F, Cossu G, Torrente Y, Politi LS (2016) Longitudinal MRI quantification of muscle degeneration in Duchenne muscular dystrophy. Ann Clin Transl Neurol 3(8):607–622

    Article  PubMed  PubMed Central  Google Scholar 

  28. Wokke BH, Van Den Bergen JC, Hooijmans MT, Verschuuren JJ, Niks EH, Kan HE (2016) T2 relaxation times are increased in Skeletal muscle of DMD but not BMD patients. Muscle Nerve 53(1):38–43

    Article  CAS  PubMed  Google Scholar 

  29. Fischer D, Hafner P, Rubino D, Schmid M, Neuhaus C, Jung H, Bieri O, Haas T, Gloor M, Fischmann A, Bonati U (2016) The 6-minute walk test, motor function measure and quantitative thigh muscle MRI in Becker muscular dystrophy: a cross-sectional study. Neuromuscul Disord 26(7):414–422

    Article  PubMed  Google Scholar 

  30. Tasca G, Monforte M, Iannaccone E, Laschena F, Ottaviani P, Leoncini E, Boccia S, Galluzzi G, Pelliccioni M, Masciullo M, Frusciante R, Mercuri E, Ricci E (2014) Upper girdle imaging in facioscapulohumeral muscular dystrophy. PLoS One 9(6):e100292. doi:10.1371/journal.pone.0100292

    Article  PubMed  PubMed Central  Google Scholar 

  31. Jordan B, Eger K, Koesling S, Zierz S (2011) Camptocormia phenotype of FSHD: a clinical and MRI study on six patients. J Neurol 258(5):866–873. doi:10.1007/s00415-010-5858-z

    Article  PubMed  Google Scholar 

  32. Regula JU, Jestaedt L, Jende F, Bartsch A, Meinck HM, Weber MA (2015) Clinical muscle testing compared with whole-body magnetic resonance imaging in facio-scapulo-humeral muscular dystrophy. Clin Neuroradiol. doi:10.1007/s00062-015-0386-y

    PubMed  Google Scholar 

  33. Gerevini S, Scarlato M, Maggi L, Cava M, Caliendo G, Pasanisi B, Falini A, Previtali SC, Morandi L (2015) Muscle MRI findings in facioscapulohumeral muscular dystrophy. Eur Radiol ((Gerevini S., simonetta.gerevini@hsr.it; Caliendo G.; Falini A.) Neuroradiology Unit, Head and Neck Department, IRCCS San Raffaele Scientific Institute, Milan, Italy)

  34. Leung DG, Carrino JA, Wagner KR, Jacobs MA (2015) Whole-body magnetic resonance imaging evaluation of facioscapulohumeral muscular dystrophy. Muscle Nerve 52(4):512–520. doi:10.1002/mus.24569

    Article  PubMed  PubMed Central  Google Scholar 

  35. Rijken NH, van Engelen BG, de Rooy JW, Geurts AC, Weerdesteyn V (2014) Trunk muscle involvement is most critical for the loss of balance control in patients with facioscapulohumeral muscular dystrophy. Clin Biomech (Bristol, Avon) 29(8):855–860. doi:10.1016/j.cl0inbiomech.2014.07.008

    Article  CAS  Google Scholar 

  36. Olsen DB, Gideon P, Jeppesen TD, Vissing J (2006) Leg muscle involvement in facioscapulohumeral muscular dystrophy assessed by MRI. J Neurol 253(11):1437–1441. doi:10.1007/s00415-006-0230-z

    Article  PubMed  Google Scholar 

  37. Iosa M, Mazza C, Frusciante R, Zok M, Aprile I, Ricci E, Cappozzo A (2007) Mobility assessment of patients with facioscapulohumeral dystrophy. Clin Biomech (Bristol, Avon) 22(10):1074–1082. doi:10.1016/j.clinbiomech.2007.07.013

    Article  CAS  Google Scholar 

  38. Tasca G, Monforte M, Ottaviani P, Pelliccioni M, Frusciante R, Laschena F, Ricci E (2016) Magnetic Resonance Imaging in a large cohort of facioscapulohumeral muscular dystrophy patients: pattern refinement and implications for clinical trials. Ann Neurol. doi:10.1002/ana.24640

    PubMed  Google Scholar 

  39. Janssen BH, Voet NB, Nabuurs CI, Kan HE, de Rooy JW, Geurts AC, Padberg GW, van Engelen BG, Heerschap A (2014) Distinct disease phases in muscles of facioscapulohumeral dystrophy patients identified by MR detected fat infiltration. PLoS One 9(1):e85416. doi:10.1371/journal.pone.0085416

    Article  PubMed  PubMed Central  Google Scholar 

  40. Lareau-Trudel E, Troter AL, Ghattas B, Pouget J, Attarian S, Bendahan D, Salort-Campana E (2015) Muscle quantitative MR imaging and clustering analysis in patients with facioscapulohumeral muscular dystrophy type 1. PLoS One 10(7): e0132717. doi:10.1371/journal.pone.0132717

  41. Kan HE, Klomp DW, Wohlgemuth M, van Loosbroek-Wagemans I, van Engelen BG, Padberg GW, Heerschap A (2010) Only fat infiltrated muscles in resting lower leg of FSHD patients show disturbed energy metabolism. NMR Biomed 23(6):563–568. doi:10.1002/nbm.1494

    Article  CAS  PubMed  Google Scholar 

  42. Friedman SD, Poliachik SL, Carter GT, Budech CB, Bird TD, Shaw DW (2012) The magnetic resonance imaging spectrum of facioscapulohumeral muscular dystrophy. Muscle Nerve 45(4):500–506. doi:10.1002/mus.22342

    Article  PubMed  Google Scholar 

  43. Janssen B, Voet N, Geurts A, Van Engelen B, Heerschap A (2016) Quantitative MRI reveals decelerated fatty infiltration in muscles of active FSHD patients. Neurology 86(18):1700–1707

    Article  CAS  PubMed  Google Scholar 

  44. Stramare R, Beltrame V, Dal Borgo R, Gallimberti L, Frigo AC, Pegoraro E, Angelini C, Rubaltelli L, Feltrin GP (2010) MRI in the assessment of muscular pathology: a comparison between limb-girdle muscular dystrophies, hyaline body myopathies and myotonic dystrophies. Radiol Med (Torino) 115(4):585–599. doi:10.1007/s11547-010-0531-2

    Article  CAS  Google Scholar 

  45. Fischer D, Walter MC, Kesper K, Petersen JA, Aurino S, Nigro V, Kubisch C, Meindl T, Lochmuller H, Wilhelm K, Urbach H, Schroder R (2005) Diagnostic value of muscle MRI in differentiating LGMD2I from other LGMDs. J Neurol 252(5):538–547. doi:10.1007/s00415-005-0684-4

    Article  PubMed  Google Scholar 

  46. Mercuri E, Bushby K, Ricci E, Birchall D, Pane M, Kinali M, Allsop J, Nigro V, Saenz A, Nascimbeni A, Fulizio L, Angelini C, Muntoni F (2005) Muscle MRI findings in patients with limb girdle muscular dystrophy with calpain 3 deficiency (LGMD2A) and early contractures. Neuromuscul Disord NMD 15(2):164–171. doi:10.1016/j.nmd.2004.10.008

    Article  PubMed  Google Scholar 

  47. Kesper K, Kornblum C, Reimann J, Lutterbey G, Schroder R, Wattjes MP (2009) Pattern of skeletal muscle involvement in primary dysferlinopathies: a whole-body 3.0-T magnetic resonance imaging study. Acta Neurol Scand 120(2):111–118. doi:10.1111/j.1600-0404.2008.01129.x

    Article  CAS  PubMed  Google Scholar 

  48. Diaz J, Woudt L, Suazo L, Garrido C, Caviedes P, Cardenas AM, Castiglioni C, Bevilacqua JA (2016) Broadening the imaging phenotype of dysferlinopathy at different disease stages. Muscle Nerve. doi:10.1002/mus.25045

    PubMed  Google Scholar 

  49. Paradas C, Llauger J, Diaz-Manera J, Rojas-Garcia R, De Luna N, Iturriaga C, Marquez C, Uson M, Hankiewicz K, Gallardo E, Illa I (2010) Redefining dysferlinopathy phenotypes based on clinical findings and muscle imaging studies. Neurology 75(4):316–323. doi:10.1212/WNL.0b013e3181ea1564

    Article  CAS  PubMed  Google Scholar 

  50. Degardin A, Morillon D, Lacour A, Cotten A, Vermersch P, Stojkovic T (2010) Morphologic imaging in muscular dystrophies and inflammatory myopathies. Skelet Radiol 39(12):1219–1227. doi:10.1007/s00256-010-0930-4

    Article  Google Scholar 

  51. Willis TA, Hollingsworth KG, Coombs A, Sveen ML, Andersen S, Stojkovic T, Eagle M, Mayhew A, de Sousa PL, Dewar L, Morrow JM, Sinclair CD, Thornton JS, Bushby K, Lochmuller H, Hanna MG, Hogrel JY, Carlier PG, Vissing J, Straub V (2014) Quantitative magnetic resonance imaging in limb-girdle muscular dystrophy 2I: a multinational cross-sectional study. PLoS One 9(2):e90377. doi:10.1371/journal.pone.0090377

    Article  PubMed  PubMed Central  Google Scholar 

  52. Mahjneh I, Bashir R, Kiuru-Enari S, Linssen W, Lamminen A, Visser M (2012) Selective pattern of muscle involvement seen in distal muscular dystrophy associated with anoctamin 5 mutations: a follow-up muscle MRI study. Neuromuscul Disord NMD 22(Suppl 2):S130–S136. doi:10.1016/j.nmd.2012.02.007

    Article  PubMed  Google Scholar 

  53. Sarkozy A, Deschauer M, Carlier RY, Schrank B, Seeger J, Walter MC, Schoser B, Reilich P, Leturq F, Radunovic A, Behin A, Laforet P, Eymard B, Schreiber H, Hicks D, Vaidya SS, Glaser D, Carlier PG, Bushby K, Lochmuller H, Straub V (2012) Muscle MRI findings in limb girdle muscular dystrophy type 2L. Neuromuscul Disord NMD 22(Suppl 2):S122–S129. doi:10.1016/j.nmd.2012.05.012

    Article  PubMed  Google Scholar 

  54. Jin SQ, Yu M, Zhang W, Lyu H, Yuan Y, Wang ZX (2016) Dysferlin gene mutation spectrum in a large cohort of chinese patients with dysferlinopathy. Chin Med J (Engl) 129(19):2287–2293. doi:10.4103/0366-6999.190671

    Article  Google Scholar 

  55. Mercuri E, Lampe A, Allsop J, Knight R, Pane M, Kinali M, Bonnemann C, Flanigan K, Lapini I, Bushby K, Pepe G, Muntoni F (2005) Muscle MRI in Ullrich congenital muscular dystrophy and Bethlem myopathy. Neuromuscul Disord NMD 15(4):303–310. doi:10.1016/j.nmd.2005.01.004

    Article  PubMed  Google Scholar 

  56. Quijano-Roy S, Avila-Smirnow D, Carlier RY, group W-Mms (2012) Whole body muscle MRI protocol: pattern recognition in early onset NM disorders. Neuromuscul Disord NMD 22(Suppl 2):S68–S84. doi:10.1016/j.nmd.2012.08.003

    Article  PubMed  Google Scholar 

  57. Mercuri E, Cini C, Pichiecchio A, Allsop J, Counsell S, Zolkipli Z, Messina S, Kinali M, Brown SC, Jimenez C, Brockington M, Yuva Y, Sewry CA, Muntoni F (2003) Muscle magnetic resonance imaging in patients with congenital muscular dystrophy and Ullrich phenotype. Neuromuscul Disord NMD 13(7–8):554–558

    Article  CAS  PubMed  Google Scholar 

  58. Gomez-Andres D, Dabaj I, Mompoint D, Hankiewicz K, Azzi V, Ioos C, Romero NB, Ben Yaou R, Bergounioux J, Bonne G, Richard P, Estournet B, Yves-Carlier R, Quijano-Roy S (2015) Pediatric laminopathies: whole-body MRI fingerprint and comparison with SEPN1-myopathy. Muscle Nerve. doi:10.1002/mus.25018

    PubMed  Google Scholar 

  59. Mercuri E, Counsell S, Allsop J, Jungbluth H, Kinali M, Bonne G, Schwartz K, Bydder G, Dubowitz V, Muntoni F (2002) Selective muscle involvement on magnetic resonance imaging in autosomal dominant Emery–Dreifuss muscular dystrophy. Neuropediatrics 33(1):10–14. doi:10.1055/s-2002-23593

    Article  CAS  PubMed  Google Scholar 

  60. Carboni N, Mura M, Marrosu G, Cocco E, Marini S, Solla E, Mateddu A, Maioli MA, Piras R, Mallarini G, Mercuro G, Porcu M, Marrosu MG (2010) Muscle imaging analogies in a cohort of patients with different clinical phenotypes caused by LMNA gene mutations. Muscle Nerve 41(4):458–463. doi:10.1002/mus.21514

    Article  CAS  PubMed  Google Scholar 

  61. Hankiewicz K, Carlier RY, Lazaro L, Linzoain J, Barnerias C, Gomez-Andres D, Avila-Smirnow D, Ferreiro A, Estournet B, Guicheney P, Germain DP, Richard P, Bulacio S, Mompoint D, Quijano-Roy S (2015) Whole-body muscle magnetic resonance imaging in SEPN1-related myopathy shows a homogeneous and recognizable pattern. Muscle Nerve 52(5):728–735. doi:10.1002/mus.24634

    Article  CAS  PubMed  Google Scholar 

  62. Jungbluth H, Davis MR, Muller C, Counsell S, Allsop J, Chattopadhyay A, Messina S, Mercuri E, Laing NG, Sewry CA, Bydder G, Muntoni F (2004) Magnetic resonance imaging of muscle in congenital myopathies associated with RYR1 mutations. Neuromuscul Disord NMD 14(12):785–790. doi:10.1016/j.nmd.2004.08.006

    Article  PubMed  Google Scholar 

  63. Jarraya M, Quijano-Roy S, Monnier N, Behin A, Avila-Smirnov D, Romero NB, Allamand V, Richard P, Barois A, May A, Estournet B, Mercuri E, Carlier PG, Carlier RY (2012) Whole-Body muscle MRI in a series of patients with congenital myopathy related to TPM2 gene mutations. Neuromuscul Disord NMD 22(Suppl 2):S137–S147. doi:10.1016/j.nmd.2012.06.347

    Article  PubMed  Google Scholar 

  64. Jungbluth H, Sewry CA, Counsell S, Allsop J, Chattopadhyay A, Mercuri E, North K, Laing N, Bydder G, Pelin K, Wallgren-Pettersson C, Muntoni F (2004) Magnetic resonance imaging of muscle in nemaline myopathy. Neuromuscul Disord NMD 14(12):779–784. doi:10.1016/j.nmd.2004.08.005

    Article  PubMed  Google Scholar 

  65. Schramm N, Born C, Weckbach S, Reilich P, Walter MC, Reiser MF (2008) Involvement patterns in myotilinopathy and desminopathy detected by a novel neuromuscular whole-body MRI protocol. Eur Radiol 18(12):2922–2936. doi:10.1007/s00330-008-1071-1

    Article  PubMed  Google Scholar 

  66. McNeill A, Birchall D, Straub V, Goldfarb L, Reilich P, Walter MC, Schramm N, Lochmuller H, Chinnery PF (2009) Lower limb radiology of distal myopathy due to the S60F myotilin mutation. Eur Neurol 62(3):161–166. doi:10.1159/000227266

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  67. Muller TJ, Kraya T, Stoltenburg-Didinger G, Hanisch F, Kornhuber M, Stoevesandt D, Senderek J, Weis J, Baum P, Deschauer M, Zierz S (2014) Phenotype of matrin-3-related distal myopathy in 16 German patients. Ann Neurol 76(5):669–680. doi:10.1002/ana.24255

    Article  PubMed  Google Scholar 

  68. Mahjneh I, Lamminen AE, Udd B, Paetau AE, Hackman P, Korhola OA, Somer HV (2004) Muscle magnetic resonance imaging shows distinct diagnostic patterns in Welander and tibial muscular dystrophy. Acta Neurol Scand 110(2):87–93. doi:10.1111/j.1600-0404.2004.00283.x

    Article  CAS  PubMed  Google Scholar 

  69. Fischmann A, Gloor M, Fasler S, Haas T, Rodoni Wetzel R, Bieri O, Wetzel S, Heinimann K, Scheffler K, Fischer D (2011) Muscular involvement assessed by MRI correlates to motor function measurement values in oculopharyngeal muscular dystrophy. J Neurol 258(7):1333–1340. doi:10.1007/s00415-011-5937-9

    Article  PubMed  Google Scholar 

  70. Zhao J, Liu J, Xiao J, Du J, Que C, Shi X, Liang W, Sun W, Zhang W, Lv H, Yuan Y, Wang Z (2015) Clinical and muscle imaging findings in 14 mainland chinese patients with oculopharyngodistal myopathy. PLoS One 10(6):e0128629. doi:10.1371/journal.pone.0128629

    Article  PubMed  PubMed Central  Google Scholar 

  71. Fu J, Zheng YM, Jin SQ, Yi JF, Liu XJ, Lyn H, Wang ZX, Zhang W, Xiao JX, Yuan Y (2016) “Target” and “sandwich” signs in thigh muscles have high diagnostic values for collagen VI-related myopathies. Chin Med J 129(15):1811–1816

    Article  PubMed  PubMed Central  Google Scholar 

  72. Fiorillo C, Astrea G, Savarese M, Cassandrini D, Brisca G, Trucco F, Pedemonte M, Trovato R, Ruggiero L, Vercelli L, D’Amico A, Tasca G, Pane M, Fanin M, Bello L, Broda P, Musumeci O, Rodolico C, Messina S, Vita GL, Sframeli M, Gibertini S, Morandi L, Mora M, Maggi L, Petrucci A, Massa R, Grandis M, Toscano A, Pegoraro E, Mercuri E, Bertini E, Mongini T, Santoro L, Nigro V, Minetti C, Santorelli FM, Bruno C (2016) MYH7-related myopathies: clinical, histopathological and imaging findings in a cohort of Italian patients. Orphanet J Rare Dis 11(1):91. doi:10.1186/s13023-016-0476-1

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  73. Sugie K, Sugie M, Taoka T, Tonomura Y, Kumazawa A, Izumi T, Kichikawa K, Ueno S (2015) Characteristic MRI findings of upper limb muscle involvement in myotonic dystrophy type 1. PLoS One 10(4):e0125051. doi:10.1371/journal.pone.0125051

    Article  PubMed  PubMed Central  Google Scholar 

  74. Kornblum C, Lutterbey G, Bogdanow M, Kesper K, Schild H, Schroder R, Wattjes MP (2006) Distinct neuromuscular phenotypes in myotonic dystrophy types 1 and 2: a whole body highfield MRI study. J Neurol 253(6):753–761. doi:10.1007/s00415-006-0111-5

    Article  PubMed  Google Scholar 

  75. Damian MS, Bachmann G, Herrmann D, Dorndorf W (1993) Magnetic resonance imaging of muscle and brain in myotonic dystrophy. J Neurol 240(1):8–12

    Article  CAS  PubMed  Google Scholar 

  76. Hamano T, Kawamura Y, Mutoh T, Hirayama M, Kuriyama M (2010) Muscle MRI in myotonic dystrophy type 1 with foot drop. Eur Neurol 63(3):144–148. doi:10.1159/000280763

    Article  PubMed  Google Scholar 

  77. Hayashi K, Hamano T, Kawamura Y, Kimura H, Matsunaga A, Ikawa M, Yamamura O, Mutoh T, Higuchi I, Kuriyama M, Nakamoto Y (2016) Muscle MRI of the upper extremity in the myotonic dystrophy type 1. Eur Neurol 76(1–2):87–94

    Article  CAS  PubMed  Google Scholar 

  78. Mercuri E, Talim B, Moghadaszadeh B, Petit N, Brockington M, Counsell S, Guicheney P, Muntoni F, Merlini L (2002) Clinical and imaging findings in six cases of congenital muscular dystrophy with rigid spine syndrome linked to chromosome 1p (RSMD1). Neuromuscul Disord NMD 12(7–8):631–638

    Article  PubMed  Google Scholar 

  79. Lamminen AE (1990) Magnetic resonance imaging of primary skeletal muscle diseases: patterns of distribution and severity of involvement. Br J Radiol 63(756):946–950. doi:10.1259/0007-1285-63-756-946

    Article  CAS  PubMed  Google Scholar 

  80. Stramare R, Beltrame V, Dal Borgo R, Gallimberti L, Frigo AC, Pegoraro E, Angelini C, Rubaltelli L, Feltrin GP (2010) MRI in the assessment of muscular pathology: a comparison between limb-girdle muscular dystrophies, hyaline body myopathies and myotonic dystrophies. Radiologia Medica ((Stramare R., roberto.stramare@unipd.it; Beltrame V.; Dal Borgo R.; Gallimberti L.; Rubaltelli L.; Feltrin G.P.) Department of Medical Diagnostic Sciences and Special Therapies, University of Padova, Padova, 35128, Italy):1–15

  81. Wagner KR, Fleckenstein JL, Amato AA, Barohn RJ, Bushby K, Escolar DM, Flanigan KM, Pestronk A, Tawil R, Wolfe GI, Eagle M, Florence JM, King WM, Pandya S, Straub V, Juneau P, Meyers K, Csimma C, Araujo T, Allen R, Parsons SA, Wozney JM, Lavallie ER, Mendell JR (2008) A phase I/IItrial of MYO-029 in adult subjects with muscular dystrophy. Ann Neurol 63(5):561–571. doi:10.1002/ana.21338

    Article  CAS  PubMed  Google Scholar 

  82. Campbell C, McMillan HJ, Mah JK, Tarnopolsky M, Selby K, McClure T, Wilson DM, Sherman ML, Escolar D, Attie KM (2016) Myostatin inhibitor ACE-031 treatment of ambulatory boys with Duchenne muscular dystrophy: results of a randomized, placebo-controlled clinical trial. Muscle Nerve. doi:10.1002/mus.25268

    Google Scholar 

  83. Sakellariou P, Kekou K, Fryssira H, Sofocleous C, Manta P, Panousopoulou A, Gounaris K, Kanavakis E (2012) Mutation spectrum and phenotypic manifestation in FSHD Greek patients. Neuromuscul Disord NMD 22(4):339–349. doi:10.1016/j.nmd.2011.11.001

    Article  CAS  PubMed  Google Scholar 

  84. Lin F, Wang ZQ, Lin MT, Murong SX, Wang N (2015) New Insights into genotype-phenotype correlations in Chinese facioscapulohumeral muscular dystrophy: a retrospective analysis of 178 patients. Chin Med J (Engl) 128(13):1707–1713. doi:10.4103/0366-6999.159336

    Article  Google Scholar 

  85. ten Dam L, van der Kooi AJ, van Wattingen M, de Haan RJ, de Visser M (2012) Reliability and accuracy of skeletal muscle imaging in limb-girdle muscular dystrophies. Neurology 79(16):1716–1723. doi:10.1212/WNL.0b013e31826e9b73

    Article  PubMed  Google Scholar 

  86. Díaz-Manera J, Alejaldre A, González L, Olivé M, Gómez-Andrés D, Muelas N, Vílchez JJ, Llauger J, Carbonell P, Márquez-Infante C, Fernández-Torrón R, Poza JJ, López de Munáin A, González-Quereda L, Mirabet S, Clarimon J, Gallano P, Rojas-García R, Gallardo E, Illa I (2016) Muscle imaging in muscle dystrophies produced by mutations in the EMD and LMNA genes. Neuromuscul Disord 26(1):33–40

    Article  PubMed  Google Scholar 

  87. Morrow JM, Matthews E, Raja Rayan DL, Fischmann A, Sinclair CD, Reilly MM, Thornton JS, Hanna MG, Yousry TA (2013) Muscle MRI reveals distinct abnormalities in genetically proven non-dystrophic myotonias. Neuromuscul Disord NMD 23(8):637–646. doi:10.1016/j.nmd.2013.05.001

    Article  PubMed  Google Scholar 

  88. Kornblum C, Lutterbey GG, Czermin B, Reimann J, von Kleist-Retzow JC, Jurkat-Rott K, Wattjes MP (2010) Whole-body high-field MRI shows no skeletal muscle degeneration in young patients with recessive myotonia congenita. Acta Neurol Scand 121(2):131–135. doi:10.1111/j.1600-0404.2009.01228.x

    Article  CAS  PubMed  Google Scholar 

  89. Horvath JJ, Austin SL, Case LE, Greene KB, Jones HN, Soher BJ, Kishnani PS, Bashir MR (2015) Correlation between quantitative whole-body muscle magnetic resonance imaging and clinical muscle weakness in Pompe disease. Muscle Nerve 51(5):722–730. doi:10.1002/mus.24437

    Article  PubMed  Google Scholar 

  90. Olsen DB, Langkilde AR, Orngreen MC, Rostrup E, Schwartz M, Vissing J (2003) Muscle structural changes in mitochondrial myopathy relate to genotype. J Neurol 250(11):1328–1334. doi:10.1007/s00415-003-0206-1

    Article  PubMed  Google Scholar 

  91. Hollingsworth KG, de Sousa PL, Straub V, Carlier PG (2012) Towards harmonization of protocols for MRI outcome measures in skeletal muscle studies: consensus recommendations from two TREAT-NMD NMR workshops, 2 May 2010, Stockholm, Sweden, 1–2 October 2009, Paris, France. Neuromuscul Disord NMD 22(Suppl 2):S54–S67. doi:10.1016/j.nmd.2012.06.005

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Center for Genetic Muscle Disorders, The Kennedy Krieger Institute, Baltimore, USA

    Doris G. Leung

  2. Department of Neurology, The Johns Hopkins School of Medicine, Baltimore, USA

    Doris G. Leung

Authors
  1. Doris G. Leung
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Doris G. Leung.

Ethics declarations

Funding

DGL receives support from a Grant from the National Institutes of Health (5 K23 NS091379-02).

Conflicts of interest

The authors declare that they have no conflict of interest.

Ethical standards

The manuscript does not contain clinical studies or patient data.

Electronic supplementary material

Below is the link to the electronic supplementary material.

Supplementary material 1 (TIFF 258 kb)

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Leung, D.G. Magnetic resonance imaging patterns of muscle involvement in genetic muscle diseases: a systematic review. J Neurol 264, 1320–1333 (2017). https://doi.org/10.1007/s00415-016-8350-6

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00415-016-8350-6

Keywords

Search

Navigation